Skip to main content
Defiance International

Published study records

Study records for Ipamorelin

Study records describe published research and its limitations. They do not establish efficacy, safety, or suitability for any use.

Study record counts

39 study records.

0 evidence-verified · 39 citation-verified · 0 citation-only

Verified records by research setting

  • Human research: 9
  • In vitro: 9
  • In vivo/preclinical: 21
  • Review/meta-analysis: 0
  • Other: 0
Filter study recordsReset filters

Current study records

Study type: Human research · Status: Citation identity verified

A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.

The Journal of sports medicine and physical fitness · 2026

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation identity verified

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Sports medicine (Auckland, N.Z.) · 2026

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation identity verified

Restoring endocrine function in women with premature ovarian insufficiency: A case series on hormonal profile reversal and conception following treatment with Ipamorelin

International Journal of Clinical Obstetrics and Gynaecology · 2026

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation identity verified

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

The American journal of sports medicine · 2026

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.

Physiology & behavior · 2024

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.

Animal reproduction science · 2024

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vitro · Status: Citation identity verified

A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.

Journal of peptide science : an official publication of the European Peptide Society · 2018

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vitro · Status: Citation identity verified

Peptidomimetic growth hormone secretagogue derivatives for positron emission tomography imaging of the ghrelin receptor.

European journal of medicinal chemistry · 2018

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vitro · Status: Citation identity verified

18 / THE GHRELIN AGONISTS, ANAMORELIN AND IPAMORELIN, ANTAGONIZE CISPLATIN-INDUCED ANOREXIA AND EMESIS IN THE FERRET

2018

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vitro · Status: Citation identity verified

Doping control container for urine stabilization: a pilot study.

Drug testing and analysis · 2017

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation identity verified

Structure-activity relationship for peptídic growth hormone secretagogues.

Drug testing and analysis · 2017

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation identity verified

Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.

Drug testing and analysis · 2015

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Ipamorelin: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.